Clearside Biomedical regains Nasdaq minimum bid price compliance via reverse split

Clearside Biomedical, Inc.

Received Nasdaq Panel letter on Oct 6, 2025 confirming compliance with Minimum Bid Price Requirement.
Compliance achieved by maintaining closing bid at $1.00+ for 10 consecutive business days after reverse stock split.
Reverse stock split effective Sept 12, 2025 was approved by stockholders and implemented to cure non-compliance.
Non-compliance notice originally received Feb 7, 2025; delisting hearing held Sept 16, 2025.

item 8.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-233470
form_type: 8-K
ticker: CLSDQ
cik: 0001539029
company_name: Clearside Biomedical, Inc.
filed_at: 2025-10-07T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.687284+00:00
generated_at: 2026-05-17T04:26:03.583893+00:00
sec_items: ["8.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-233470
json_url: https://secwatch.observer/filing/0001193125-25-233470.json
markdown_url: https://secwatch.observer/filing/0001193125-25-233470.md
text_url: https://secwatch.observer/filing/0001193125-25-233470.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1539029/000119312525233470/0001193125-25-233470-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1539029/000119312525233470/clsd-20251007.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-25-233470

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.